ARTICLE | Clinical News
Octamer Inc. regulatory update
December 6, 1993 8:00 AM UTC
Octamer received U.S. Patent No. 5,262,564 covering sulfinic acid adducts of nitroso compounds. The compounds eject zinc from zinc fingers, inactivating retroviruses and killing tumor cells. Octamer s...